Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling

Cellular and Molecular Neurobiology

Volumn 23, Issue 3, 2003, Pages 305-314

  Insel, Paul A ^a,b   Ostrom, Rennolds S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenylyl cyclase; ATP release; Forskolin; G protein coupled receptors; Gs; P2Y receptors; Stoichiometry

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; APYRASE; CYCLIC AMP; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE; INDOMETACIN; NEUROTRANSMITTER; PROSTAGLANDIN;

AUTOCRINE EFFECT; ENZYME ACTIVATION; NERVOUS SYSTEM; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY;

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ANIMALS; CELL MEMBRANE; CYCLIC AMP; EUKARYOTIC CELLS; FORSKOLIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; HUMANS; SIGNAL TRANSDUCTION;

EID: 0038728629     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023684503883     Document Type: Review

References (54)

1. s-adenylate cyclase interactions. FASEB J. 5:2300-2303.
2. Appel, N. M., Robbins, J. D., De Souza, E. B., and Seamon, K. B. (1992). [125I]-Labeled forskolin analogs which discriminate adenylyl cyclase and a glucose transporter: Pharmacological characterization and localization of binding sites in rat brain by in vitro receptor autoradiography. J. Pharmacol. Exp. Ther. 263:1415-1423.
3. Barber, R. (1988). Forskolin binding to intact S49 lymphoma cells. Second Messengers Phosphoproteins 12:59-71.
4. Beavo, J. A., and Brunton, L. L. (2002). Cyclic nucleotide research-Still expanding after half a century. Nat. Rev. Mol. Cell. Biol. 3:710-718.
5. Bender, J. L., and Neer, E. J. (1983). Properties of the adenylate cyclase catalytic unit from caudate nucleus. J. Biol. Chem. 258:2432-2439.
6. Cassel, D., and Selinger, Z. (1977). Mechanism of adenylate cyclase activation by cholera toxin: Inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. U.S.A. 74:3307-3311.
7. Cerione, R. A., Sibley, D. R., Codina, J., Benovic, J. L., Winslow, J., Neer, E. J., Birnbaumer, L., Caron, M. G., and Lefkowitz, R. J. (1984). Reconstitution of a hormone-sensitive adenylate cyclase system. The pure beta-adrenergic receptor and guanine nucleotide regulatory protein confer hormone responsiveness on the resolved catalytic unit. J. Biol. Chem. 259:9979-9982.
8. Daly, J. W. (1984). Forskolin, adenylate cyclase, and cell physiology: An overview. Adv. Cyclic Nucleotide Prot. Phosph. Res. 17:81-89.
9. Daly, J. W., Padgett, W., and Seamon, K. B. (1982). Activation of cyclic AMP-generating systems in brain membranes and slices by the diterpene forskolin: Augmentation of receptor-mediated responses. J. Neurochem. 38:532-544.
10. Darfler, F. J., Mahan, L. C., Koachman, A. M., and Insel, P. A. (1982). Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J. Biol. Chem. 257:11901-11907.
11. Dessauer, C. W., Scully, T. T., and Gilman, A. G. (1997). Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase. J. Biol. Chem. 272:22272-22277.
12. Dessauer, C. W., Tesmer, J. J., Sprang, S. R., and Gilman, A. G. (1998). Identification of a Gi alpha binding site on type V adenylyl cyclase. J. Biol. Chem. 273:25831-25839.
13. 2+ entry requires localization in cholesterol-rich domains. J. Biol. Chem. 275:26530-26537.
14. Gao, M., Ping, P., Post, S., Insel, P. A., Tang, R., and Hammond, H. K. (1998). Increased expression of adenylyl cyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc. Nat. Acadv Sci. U.S.A. 95:1038-1043.
15. Green, D. A., and Clark, R. B. (1982a). Direct evidence for the role of the coupling proteins in forskolin activation of adenylate cyclase. J. Cyclic Nucleotide Res. 8:337-346.
16. Green, D. A., and Clark, R. B. (1982b). Direct evidence for the role of the coupling proteins in forskolin activation of adenylate cyclase. J. Cyclic Nucleotide Res. 8:337-346.
17. Hanoune, J., and Defer, N. (2001). Regulation and role of adenylyl cyclase isoforms. Annu. Rev. Pharmacol. Toxicol. 41:145-174.
18. Jasper, J. R., Michel, M. C., and Insel, P. A. (1988). Molecular mechanism of beta-adrenergic receptor blockers with intrinsic sympathomimetic activity. FASEB J. 2:2891-2894.
19. Jasper, J. R., Post, S. R., Desai, K. H., Insel, P. A., and Bernstein, D. (1995). Colchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions. J. Pharmacol. Exp. Ther. 274:937-942.
20. Laurenza, A., Robbins, J. D. and Seamon, K. B. (1992). Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: Synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase. Mol. Pharmacol. 41:360-368.
21. Laurenza, A., and Seamon, K. B. (1991). High-affinity binding sites for [3H]forskolin. Methods Enzymol. 195:52-65.
22. Lazarowski, E. R., Homolya, L., Boucher, R. C., and Harden, T. K. (1997). Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J. Biol. Chem. 272:24348-24354.
23. Lazarowski, E. R., and Harden, T. K. (1999). Quantitation of extracellular UTP using a sensitive enzymatic assay. Br. J. Pharmacol. 127:1272-1278.
24. s-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. J. Biol. Chem. 268:3833-3837.
25. MacEwan, D. J., Kim, G. D., and Milligan, G. (1996). Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptormediated stimulation of adenylate cyclase activity. Biochem. J. 318:1033-1039.
26. May, D. C., Ross, E. M., Gilman, A. G., and Smigel, M. D. (1985). Reconstitution of catecholaminestimulated adenylate cyclase activity using three purified proteins. J. Biol. Chem. 260:15829-15833.
27. Milligan, G. (1996). The stoichiometry of expression of protein components of the stimulatory adenylyl cyclase cascade and the regulation of information transfer. Cell. Signall. 8:87-95.
28. Morris, D. I., Robbins, J. D., Ruoho, A. E., Sutkowski, E. M., and Seamon, K. B. (1991a). Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose transporter. J Biol. Chem. 266:13377-13384.
29. Morris, D. I., Speicher, L. A., Ruoho, A. E., Tew, K. D., and Seamon, K. B. (1991b). Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry 30:8371-8379.
30. Ono, K., Fozzard, H. A., and Hanck, D. A. (1995). A direct effect of forskolin on sodium channel bursting. Pflugers Arch. 429:561-569.
31. Ostrom, R. S., Gregorian, C., and Insel, P. A. (2000a). Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J. Biol. Chem. 275:11735-11739.
32. Ostrom, R. S., Liu, X., Head, B. P., Gregorian, C., Seasholtz, T. M., and Insel, P. A. (2002). Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: Expression in caveolin-rich and non-caveolin domains. Mol. Pharmacol. 62:983-992.
33. s. J. Pharmacol. Exp. Ther. 294:407-412.
34. Ostrom, R. S., Violin, J. D., Coleman, S., and Insel, P. A. (2000c). Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: Colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol. Pharmacol. 57:1075-1079.
35. Pfeuffer, E., and Pfeuffer, T. (1989). Affinity labeling of forskolin-binding proteins. Comparison between glucose carrier and adenylate cyclase. FEBS Lett. 248:13-17.
36. Post, S. R., Aguila-Buhain, O., and Insel, P. A. (1996). A key role for protein kinase A in homologous desensitization of the beta 2-adrenergic receptor pathway in S49 lymphoma cells. J. Biol. Chem. 271:895-900.
37. Post, S. R., Hilal-Dandan, R., Urasawa, K., Brunton, L. L., and Insel, P. A. (1995). Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem. J. 311:75-80.
38. Robbins, J. D., Appel, N. M., Laurenza, A., Simpson, I. A., De Souza, E. B., and Seamon, K. B. (1992). Differential identification and localization of adenylyl cyclase and glucose transporter in brain using iodinated derivatives of forskolin. Brain Res. 581:148-152.
39. Rybin, V. O., Xu, X., Lisanti, M. P., and Steinberg, S. F. (2000). Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem. 275:41447-41457.
40. Schwencke, C., Okumura, S., Yamamoto, M., Geng, Y. J., and Ishikawa, Y. (1999). Colocalization of beta-adrenergic receptors and caveolin within the plasma membrane. J. Cell. Biochem. 75:64-72.
41. Seamon, K. B., Daly, J. W., Metzger, H., de Souza, N. J., and Reden, J. (1983). Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives. J. Med. Chem. 26:436-439.
42. Seamon, K. B., Padgett, W., and Daly, J. W. (1981). Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. U.S.A. 78:3363-3367.
43. Seamon, K. B., Vaillancourt, R., Edwards, M., and Daly, J. W. (1984). Binding of [3H]forskolin to rat brain membranes. Proc. Natl. Acad. Sci. U.S.A. 81:5081-5085.
44. Shanahan, M. F., Morris, D. P., and Edwards, B. M. (1987). [3H]forskolin. Direct photoaffinity labeling of the erythrocyte D-glucose transporter. J. Biol. Chem. 262:5978-5984.
45. Sievert, M. K., Pilli, G., Liu, Y., Sutkowski, E. M., Seamon, K. B., and Ruoho, A. E. (2002). Photoaffinity labeling of adenylyl cyclase. Methods Enzymol. 345:188-197.
46. Steinberg, S. F., and Brunton, L. L. (2001). Compartmentation of g protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol. 41:751-773.
47. Sternweis, P. C., and Gilman, A. G. (1982). Aluminum: A requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc. Natl. Acad. Sci. U.S.A. 79:4888-4891.
48. s alpha. Biochemistry 33:12852-12859.
49. salpha. GTP gammas. Science 278:1907-1916.
50. Torres, B., Zambon, A. C., and Insel, P. A. (2002). P2Y11 receptors activate adenylyl cyclase and contribute to nucleotide-promoted cAMP formation in MDCK-D(1) cells. A mechanism for nucleotidemediated autocrine-paracrine regulation. J. Biol. Chem. 277:7761-7765.
51. Wadzinski, B. E., Shanahan, M. F., and Ruoho, A. E. (1987). Derivatization of the human erythrocyte glucose transporter using a novel forskolin photoaffinity label. J. Biol. Chem. 262:17683-17689.
52. Zhang, G., Liu, Y., Ruoho, A. E., and Hurley, J. H. (1997). Structure of the adenylyl cyclase catalytic core. Nature 386:247-253.
53. Zheng, B., Ma, Y. C., Ostrom, R. S., Lavoie, C., Gill, G. N., Insel, P. A., Huang, X. Y., and Farquhar, M. G. (2001). RGS-PX1, a GAP for G alpha s and sorting nexin in vesicular trafficking. Science 294:1939-1942.
54. Zhong, H., Guerrero, S. W., Esbenshade, T. A., and Minneman, K. P. (1996). Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: Functional interactions between closely related subtypes. Mol. Pharmacol. 50:175-184.